News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|March 25, 2024

Identifying Social Determinants of Health in Cardiovascular Care

Medical experts emphasize the importance of partnering with community leaders to address social determinants of health that act as barriers to care.

Episodes in this series

EP. 1 Disparities in Cardiovascular Care for Diverse Populations

EP. 1 Disparities in Cardiovascular Care for Diverse Populations

EP. 2 Innovation vs Access: Supporting Underserved Communities

EP. 2 Innovation vs Access: Supporting Underserved Communities

EP. 3 Exploring Polypharmacy: Adherence, Communication, and Outcomes

EP. 3 Exploring Polypharmacy: Adherence, Communication, and Outcomes

EP. 4 Gender-Based Disparities in Cardiovascular Disease

EP. 4 Gender-Based Disparities in Cardiovascular Disease

Video 5 - "Peripheral Arterial Disease Awareness for Minority Populations"

EP. 5 Peripheral Arterial Disease Awareness for Minority Populations

Video 6 - "Community Partnership: Increasing Public Awareness of CVD"

EP. 6 Community Partnership: Increasing Public Awareness of CVD

Video 6 - "Community Partnership: Increasing Public Awareness of CVD"

EP. 7 Recent Data Reveals Disparities in Cardiovascular Care

Video 6 - "Community Partnership: Increasing Public Awareness of CVD"

EP. 8 Identifying Social Determinants of Health in Cardiovascular Care

Video 9 - "Impact of Novel Medications and Out-Of-Pocket Costs in Managing Cardiovascular Disease"

EP. 9 Impact of Novel Medications and Out-Of-Pocket Costs in Managing Cardiovascular Disease

video 10 - "Developing Practical Solutions to Improve Cardiovascular Care"

EP. 10 Developing Practical Solutions to Improve Cardiovascular Care

video 10 - "Developing Practical Solutions to Improve Cardiovascular Care"

EP. 11 Advancing Cardiovascular Care Through Technological Innovation

video 10 - "Developing Practical Solutions to Improve Cardiovascular Care"

EP. 12 Desired Technology Innovations to Prevent Cardiovascular Disease

Video 13 - "Measuring Implicit Bias"

EP. 13 Measuring Implicit Bias

Video 14 - "Achieving Equitable Representation in Clinical Studies"

EP. 14 Achieving Equitable Representation in Clinical Studies

Video 15 - "Ensuring Fair Cardiovascular Care for All: Concluding Perspectives on Disparities and Inclusion"

EP. 15 Ensuring Fair Cardiovascular Care for All: Concluding Perspectives on Disparities and Inclusion

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Car exhaust | Image Credit: olando - stock.adobe.com

FITs Offer Lowest Environmental Footprint Among CRC Screening Options

ByBrooke McCormick

August 17th 2026

COVID | Image credit: phonlamaiphoto - stock.adobe.com

COVID Is Back in the Bay Area: Is It the XFG "Stratus" Variant?

BySabrina McCrear

August 17th 2026

Zanubrutinib | Image Credit: © luchschenF-stock.adobe.com

Zanubrutinib Outlasting Acalabrutinib in CLL

ByMaggie L. Shaw

August 17th 2026

Helen Nde, MPH

Hepatitis B Re-Engagement Efforts Underreported in Lower-Resource Settings: Helen Nde, MPH

ByBrooke McCormick,Helen Nde, MPH,Laura Joszt, MA

August 17th 2026

Brittany G. Craiglow, MD, FAAD in part 3 of an AJMC interview

Closing Evidence Gaps in Managed Care for Pediatric Alopecia Areata: A Q&A With Brittany Craiglow, MD

BySkylar Jeremias,Brittany G. Craiglow, MD, FAAD

August 17th 2026

Trending on AJMC

COVID Is Back in the Bay Area: Is It the XFG "Stratus" Variant?

What Comes After Anti-VEGF in Wet AMD: Arshad Khanani, MD

Zanubrutinib Outlasting Acalabrutinib in CLL

FDA Clears Lerodalcibep-Liga Autoinjector, Widens LDL-C Indication

Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care